Research compounds Early human study Hormone research
Also discussed as: Growth hormone releasing peptide-2
What it is and how it works
GHRP-2 acts at the growth-hormone secretagogue receptor, a receptor also involved in ghrelin signaling. Research has explored hormone release and appetite responses. These are measurable biological effects, but neither is a complete assessment of health or performance.
Source for the mechanism context →A closer look at the cited evidence
Early human study
This label describes the selected source below. It is not a complete ranking of the literature, a safety score, or an approval status.
- Study or assessment
- Laferrere et al., 2005 — GHRP-2 and food intake
- Design
- Small experimental comparison of GHRP-2 and saline.
- Who or what was studied
- Seven lean, healthy men.
- What was observed
- Participants ate more during the GHRP-2 condition than during the saline condition.
- Limits of interpretation
- A short-term appetite experiment does not establish long-term body-composition benefits, safety, or an appropriate clinical use.
What the evidence means
The clinical question and study population matter more than a broad performance claim.
Approval and regulatory context
Not an FDA-approved performance medicine.
Safety and uncertainty
Serious events reported; causality remains uncertain.
What remains uncertain
An appetite or hormone effect can have different implications depending on the clinical question. The experiment cannot resolve longer-term outcomes, risks in other populations, or claims about a wellness protocol.
These summaries are introductory and are not a complete account of the literature, adverse effects, contraindications, or interactions. Absence of a listed risk does not mean absence of risk. Different compounds, formulations, and routes cannot be treated as interchangeable.
Sources behind this overview
Read the source in its full context. Source links support the overview; they do not imply endorsement of this library by the source organization.